Abstract:The CRISPR-Cas technology has sparked a new technological revolution, significantly enhancing our ability to understand and engineer organisms. The nuclease that underpins this technology is evolving from the “One Cas9 for all” model to a diverse CRISPR toolbox. Identifying PAM sequences is a critical bottleneck in developing novel Cas proteins. Given the limitations of experimental methods, bioinformatics approaches are essential for predicting PAM sequences of Cas proteins in advance. To date, there are only a few PAM sequence prediction programs, and their accuracy is relatively low due to the limited number of spacers in CRISPR-Cas systems. To overcome this challenge, we have developed a pipeline named PAMPHLET, which innovatively utilizes homology searches of Cas proteins to identify additional spacers. PAMPHLET was tested on 20 CRISPR-Cas systems with known PAMs, increasing the number of spacers by up to 18-fold compared to the original datasets and successfully predicting 18 PAM sequences for protospacers. For rigorous and high-quality wet-lab validation of the predictions made by PAMPHLET, we employed the published DocMF platform. This platform leverages next-generation sequencing chips to profile protein-DNA interactions and can simultaneously screen both 5’ and 3’ PAMs with high throughput. The PAMPHLET predictions showed high consistency with the DocMF results for four novel Cas proteins. We expect that PAMPHLET will overcome the current limitations in PAM sequence prediction, expedite the discovery of PAM sequences, and help to shorten the development cycle for CRISPR tools. Remarkably, PAMPHLET has revealed an intriguing genomic phenomenon: the C2c9 and C2c10 systems, which lack the canonical adaptation module, possess identical PAM sequences to those found in co-occurring type I systems, suggesting potential shared spacer acquisition mechanisms. This finding highlights the complex evolutionary relationships of CRISPR-Cas systems and propels us toward a deeper understanding of their mechanistic diversity and adaptability.

Efficient Cleavage Resolves PAM Preferences of CRISPR-Cas in Human Cells.

SaCas9 Requires 5'-NNGRRT-3' PAM for Sufficient Cleavage and Possesses Higher Cleavage Activity Than SpCas9 or FnCpf1 in Human Cells.

Diverse noncanonical PAMs recognized by SpCas9 in human cells

Expanding PAM recognition and enhancing base editing activity of Cas9 variants with non‐PI domain mutations derived from xCas9

PAMPHLET: A Robust Toolkit for Precise PAM Prediction and Unveiling PAM Consistency in Highly Co-occurrence CRISPR-Cas Systems

Comparison of Non-Canonical PAMs for CRISPR/Cas9-mediated DNA Cleavage in Human Cells

Uracil-Mediated New Photospacer-Adjacent Motif of Cas12a to Realize Visualized DNA Detection at the Single-Copy Level Free from Contamination.

PAMPHLET: PAM Prediction HomoLogous-Enhancement Toolkit for precise PAM prediction in CRISPR-Cas systems

Quantification of the affinities of CRISPR–Cas9 nucleases for cognate protospacer adjacent motif (PAM) sequences

Programming PAM antennae for efficient CRISPR-Cas9 DNA editing

In-depth assessment of the PAM compatibility and editing activities of Cas9 variants

A small PAM optimises target recognition in the CRISPR-Cas immune system

Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease

PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures

Evolved Cas9 variants with broad PAM compatibility and high DNA specificity

Engineer Chimeric Cas9 to Expand PAM Recognition Based on Evolutionary Information

A Cas9 with PAM recognition for adenine dinucleotides

A Cas12a Ortholog with Stringent PAM Recognition Followed by Low Off-Target Editing Rates for Genome Editing.

Compact SchCas9 Recognizes the Simple NNGR PAM

PAM recognition by miniature CRISPR-Cas14 triggers programmable double-stranded DNA cleavage

PAM-free diagnostics with diverse type V CRISPR-Cas systems